oral anti-acid treatment for Gastrocutaneous Fistula

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Gastrocutaneous Fistula+1 Moreoral anti-acid treatment - Drug
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at whether a non-surgical bundle can help prevent or treat gastrocutaneous fistulas, which are a common complication of gastrostomy tubes.

Eligible Conditions
  • Gastrocutaneous Fistula
  • Gastrostomy Complications

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 month

1 month
Caregiver satisfaction Survey
Gastrocutaneous Fistula (GCF)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

Intervention
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: oral anti-acid treatment · No Placebo Group · Phase 4

Intervention
Drug
Experimental Group · 1 Intervention: oral anti-acid treatment · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,328 Previous Clinical Trials
1,534,587 Total Patients Enrolled
St. Justine's HospitalOTHER
179 Previous Clinical Trials
76,985 Total Patients Enrolled
Montreal Children's Hospital of the MUHCOTHER
25 Previous Clinical Trials
8,754 Total Patients Enrolled

Eligibility Criteria

Age < 65 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: